CASP2 and hepatocellular carcinoma: Consistently, expression levels of well‐known proliferation markers such as Ki67 also correlated with a shorter recurrence‐free survival, similar to the reduced survival noted for patients with high CASP2‐expressing HCC (Figs 5B and C, and EV4C).